|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/22 | |
| A61K 38/26 | |||
| A61P 3/06 | |||
| A61P 9/10 |
| (11) | Number of the document | 2303313 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09751513.4 |
| Date of filing the European patent application | 2009-05-20 | |
| (97) | Date of publication of the European application | 2011-04-06 |
| (45) | Date of publication and mention of the grant of the patent | 2015-10-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/044727 |
| Date | 2009-05-20 |
| (87) | Number | WO 2009/143285 |
| Date | 2009-11-26 |
| (30) | Number | Date | Country code |
| 54883 P | 2008-05-21 | US |
| (72) |
FINEMAN, Mark, US
MACCONELL, Leigh, US
TAYLOR, Kristin, US
|
| (73) |
AstraZeneca Pharmaceuticals LP,
1800 Concord Pike, Wilmington, DE,
US
Amylin Pharmaceuticals, LLC, 1800 Concord Pike, Wilmington, DE 19850, US |
| (54) | EXENDINS TO LOWER CHOLESTROL AND TRIGLYCERIDES |
| EXENDINS TO LOWER CHOLESTROL AND TRIGLYCERIDES |